Tumors from both s.c. and orthotopic efficacy studies were formalin-fixed, embedded in paraffin and subjected to immunohistochemical analysis via staining with antibodies directed against CD8 (Abcam, ab203035), αSMA (Santa Cruz Biotechnology, A1218), pSTAT3 (Cell Signaling Technology, Inc., 9145L), CD11c (Abcam, ab33483), CD45R/B220 (Fisher Scientific, BDB557390), and F4/80 (Abcam, ab100790). For analysis, images were acquired at 10x and 20x magnification (approximately 5-25 pictures per mouse depending on the size of the tumor) and captured using NDP.View2 software (Hamamatsu Photonics K.K., Japan). Pictures for the staining of pSTAT3 and CD8 were analyzed by Fiji ImageJ (GitHub) to quantify the percentage of positive cells or the count of the positive cells. CellProfiler (Broad institute, Cambridge, MA) was used to analyze the αSMA staining pictures. (28 (link),29 (link)) Qupath, was used to quantify the staining for CD11c, B220 and F4/80. Orthotopic tumors were also stained for DAPI (Perkin Elmer), CD4 (Abcam, ab183685) and FOXP3 (Novus Biologicals, NB100-39002) and then visualized using a Vectra Polaris immunofluorescent whole slide scanner. Qupath was used to quantify the number of CD4+FOXP3 and CD4+FOXP3+ cells per cm2 tissue. (30 (link))